Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Im Cannabis Corp (IMCC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: IMCC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.22
1 Year Target Price $8.22
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 25.95% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.56M USD | Price to earnings Ratio - | 1Y Target Price 8.22 |
Price to earnings Ratio - | 1Y Target Price 8.22 | ||
Volume (30-day avg) 1 | Beta 1.99 | 52 Weeks Range 0.93 - 7.12 | Updated Date 01/9/2026 |
52 Weeks Range 0.93 - 7.12 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.49 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.97% | Operating Margin (TTM) -7.78% |
Management Effectiveness
Return on Assets (TTM) -6.72% | Return on Equity (TTM) -119.75% |
Valuation
Trailing PE - | Forward PE 16.31 | Enterprise Value 18097718 | Price to Sales(TTM) 0.14 |
Enterprise Value 18097718 | Price to Sales(TTM) 0.14 | ||
Enterprise Value to Revenue 0.48 | Enterprise Value to EBITDA 6.32 | Shares Outstanding 5246812 | Shares Floating 2331159 |
Shares Outstanding 5246812 | Shares Floating 2331159 | ||
Percent Insiders 44.66 | Percent Institutions 18.37 |
Upturn AI SWOT
Im Cannabis Corp
Company Overview
History and Background
IM Cannabis Corp. (formerly International Milling Corp.) was founded in 1998. The company, initially focused on the milling industry, pivoted to the cannabis sector in recent years. Significant milestones include its rebranding to IM Cannabis Corp. and strategic acquisitions within the Canadian cannabis market.
Core Business Areas
- Brand Development and Sales: Development and sale of cannabis brands to consumers through various retail channels in Canada.
- Cultivation and Production: Cultivation of cannabis at its facilities, focusing on quality and consistency.
- Wholesale and Distribution: Supplying cannabis products to licensed retailers and other licensed producers in Canada.
Leadership and Structure
IM Cannabis Corp. is led by a management team with experience in various industries. The organizational structure typically includes departments for cultivation, sales, marketing, finance, and operations, overseen by a board of directors.
Top Products and Market Share
Key Offerings
- Product Name 1: WAGNERS (Flower, Edibles, Pre-rolls) - A flagship brand offering a range of cannabis products. Competitors include Canopy Growth's Tweed, Aphria/Tilray's various brands, and Aurora Cannabis' brands. Specific market share data for individual product lines is not readily available publicly, but it operates within the competitive Canadian adult-use cannabis market.
- Product Name 2: HIGH 90 (Flower, Vapes) - Another brand focusing on premium cannabis products. Competitors are similar to WAGNERS, with a focus on the premium segment.
- Product Name 3: Quatre Soils (Flower) - A brand focused on artisanal, high-quality cannabis flower. Competitors include other craft cannabis producers and premium lines from larger LPs.
Market Dynamics
Industry Overview
The Canadian cannabis industry is a highly regulated and rapidly evolving market. It is characterized by intense competition, evolving consumer preferences, and ongoing regulatory changes. The market is transitioning from a nascent stage to a more mature, albeit still growing, sector.
Positioning
IM Cannabis Corp. positions itself as a brand-focused company with a portfolio of established and emerging cannabis brands catering to different consumer segments within the Canadian market. Its strategy relies on brand building and efficient supply chain management.
Total Addressable Market (TAM)
The total addressable market for legal cannabis in Canada is estimated to be in the billions of Canadian dollars and is expected to continue growing. IM Cannabis Corp. is positioned to capture a portion of this market through its brand offerings and distribution network, but faces significant competition from larger, more established players.
Upturn SWOT Analysis
Strengths
- Established brands with a presence in the Canadian market.
- Focus on brand development and marketing.
- Experienced management team.
- Strategic partnerships and distribution channels.
Weaknesses
- Smaller market share compared to major Canadian LPs.
- Dependence on the Canadian market.
- Brand recognition may not be as strong as some competitors.
- Profitability challenges in a competitive landscape.
Opportunities
- Expansion into new product categories (e.g., beverages, topicals).
- International market expansion as regulations permit.
- Consolidation within the Canadian cannabis industry.
- Development of new and innovative cannabis products.
Threats
- Intense competition from established and new players.
- Evolving regulatory landscape and potential changes.
- Price compression due to oversupply.
- Black market competition.
- Economic downturns impacting consumer spending.
Competitors and Market Share
Key Competitors
- Canopy Growth Corporation (CGC)
- Tilray Brands, Inc. (TLRY)
- Aurora Cannabis Inc. (ACB)
- Cronos Group Inc. (CRON)
Competitive Landscape
IM Cannabis Corp. faces intense competition from larger, well-capitalized players in Canada. Its advantage lies in its brand focus and agility, while disadvantages include its smaller scale and brand recognition compared to industry leaders.
Growth Trajectory and Initiatives
Historical Growth: IM Cannabis Corp. has undergone significant transformation, pivoting to the cannabis sector and pursuing growth through brand development and strategic initiatives within the Canadian market. Growth has been influenced by market expansion and competitive pressures.
Future Projections: Future growth is projected to be driven by brand expansion, market penetration, and potential international opportunities. Analyst estimates for future growth should be consulted for specific projections.
Recent Initiatives: Recent initiatives likely include the launch of new product lines, marketing campaigns, and potentially strategic partnerships or operational optimizations to improve efficiency and profitability.
Summary
IM Cannabis Corp. is a Canadian cannabis company focused on brand development and sales. While it has established brands, it operates in a highly competitive market with significant challenges in achieving consistent profitability. Its future success will depend on its ability to differentiate its brands, expand its market reach, and navigate the evolving regulatory and economic landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC filings (10-K, 10-Q)
- Company investor relations website
- Reputable financial news outlets
- Industry analysis reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Im Cannabis Corp
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-05-20 | CEO & Executive Director Mr. Oren Shuster | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees - | Website https://imcannabis.com |
Full time employees - | Website https://imcannabis.com | ||
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.